Dry Eye

Diabetes Exacerbates Dry Eye Symptoms, Study Shows

Type 2 patients suffered more severe lid margin and tear film abnormalities than those without the disease in a recent study.

06/26/2025

TFOS DEWS III Treatment Report Details Full Panoply of Interventions

The comprehensive document showcases every option and aims to link specific ones to certain dry eye subtypes when possible. It also elevates the role of lifestyle modifications.

06/13/2025

Combining Low-level Light Therapy with IPL Most Effective for MGD

Compared with LLLT alone, adding the latter procedure further improved symptom frequency and severity and increased cellular metabolism.

06/12/2025

TFOS DEWS III Refines Key Diagnostic Protocols, Emphasizes Importance of Subtyping

The new report endorses a simpler patient screening questionnaire and links specific disease characteristics to treatment approaches. The definition of dry eye has also been tweaked to emphasize symptomatic involvement.

06/02/2025

Sleep Apnea Associated with Threefold Higher Risk of DED

While these patients are more likely to have diabetes and obesity, the ocular connection should be more prominently considered by caregivers, according to an ARVO abstract.

05/15/2025

Dry Eye Therapies: Every Drug, Tool and Trick We Have

This pervasive condition has prompted the development of dozens—perhaps hundreds—of products and procedures. Below, we attempt a narrative of the entire slate.

05/15/2025

Get in the Game

Don’t sit on the sidelines when it comes to DED.

05/15/2025

Antidepressants’ Impact on Ocular Health

Learn how to manage patients on these medications and the importance of collaborating with various specialists, including those specializing in mental health.

05/15/2025

The Role of Intense Pulsed Light in OSD Management

Learn how to use this advanced procedure to effectively treat patients with ocular rosacea, MGD, Demodex blepharitis, hordeola, chalazia and more.

05/15/2025

Placebo Effects in DED Studies Associated with Women and Lower Baseline Scores

Analysis of previous clinical trials identified significant influence as measured by OSDI, as well as the signs TBUT, corneal staining and conjunctival staining.

05/14/2025